Plasma levels of LCN2 are significantly elevated in ischemic stroke patients with unfavorable modified Rankin scale scores [13,14], post-stroke infections [14], hemorrhagic transformations after tPA treatments [15], and cardiovascular mortality [16]. Here, LCN2 is linked to stroke disorder.